Sort
16,300 grants matching “fatty liver disease”
Isolation and Characterization of Low Molecular Weight Compounds Derived from Plant Extracts that Activate the IRS-2 Dependent Insulin Signaling Cascade.
$170,341Gerard M Housey · Housey Pharmaceutical Research Lab · R43 · FY2015 · DK
EFFECT OF HIGH FRUCTOSE CORN SYRUP FEEDING IN NONALCOHOLIC FATTY LIVER DISEASE
$170,258Shelby A Sullivan · Washington University · K23 · FY2013 · DK
DMGV and the AGXT2 pathway in chronic exercise-induced cardiometabolic adaptations.
$170,224Jeremy Robbins · Beth Israel Deaconess Medical Center · K23 · FY2020 · HL
Effect of Hepatotoxins &Adomet on Liver Gene Expression
$170,000Fox Chase Cancer Center · R21 · FY2003 · AA
Effect of Hepatotoxins &Adomet on Liver Gene Expression
$170,000Fox Chase Cancer Center · R21 · FY2002 · AA
EFFECT OF HIGH FRUCTOSE CORN SYRUP FEEDING IN NONALCOHOLIC FATTY LIVER DISEASE
$169,972Shelby A Sullivan · Washington University · K23 · FY2014 · DK
Leveraging the Gut Microbiome to Regulate Hepatic Gluconeogenesis
$169,884Tibor Krisko · Weill Medical Coll Of Cornell Univ · K08 · FY2022 · DK
Translational investigation of abnormal fat metabolism in mitochondrial disease
$169,799Shana Erin McCormack · Children'S Hosp Of Philadelphia · K23 · FY2017 · DK
DMGV and the AGXT2 pathway in chronic exercise-induced cardiometabolic adaptations.
$169,650Jeremy Robbins · Beth Israel Deaconess Medical Center · K23 · FY2021 · HL
Impact of Meal Timing on Glycemic Profiles in Adolescents with Type 2 Diabetes
$169,572Alaina P Vidmar · Children'S Hospital Of Los Angeles · K23 · FY2023 · DK
Longevity foods, SIRT activation and diabetic dyslipidemia.
$169,540Pratibha V Nerurkar · University Of Hawaii At Manoa · R21 · FY2008 · AT
Targeting Diabetes With Novel Small Molecule Therapeutics
$169,500Djamel Lebeche · Icahn School Of Medicine At Mount Sinai · R56 · FY2015 · DK
Pre-clinical Testing of a Novel Therapeutic for Nonalcoholic Steatohepatitis
$169,419Scott Laurence Friedman · Icahn School Of Medicine At Mount Sinai · UH3 · FY2019 · TR
EFFECT OF HIGH FRUCTOSE CORN SYRUP FEEDING IN NONALCOHOLIC FATTY LIVER DISEASE
$169,368Shelby A Sullivan · Washington University · K23 · FY2015 · DK
Predictive models for incident cirrhosis in non-alcoholic fatty liver disease using genetic and electronic medical record-based risk factors
$169,300Vincent Lingzhi Chen · University Of Michigan At Ann Arbor · K08 · FY2022 · DK
Predictive models for incident cirrhosis in non-alcoholic fatty liver disease using genetic and electronic medical record-based risk factors
$169,240Vincent Lingzhi Chen · University Of Michigan At Ann Arbor · K08 · FY2023 · DK
Noninvasive detection of NASH by magnetic resonance elastography (MRE)
$169,128Alina M Allen · Mayo Clinic Rochester · K23 · FY2019 · DK
Noninvasive detection of NASH by magnetic resonance elastography (MRE)
$169,128Alina M Allen · Mayo Clinic Rochester · K23 · FY2018 · DK
Noninvasive detection of NASH by magnetic resonance elastography (MRE)
$169,128Alina M Allen · Mayo Clinic Rochester · K23 · FY2020 · DK
Noninvasive detection of NASH by magnetic resonance elastography (MRE)
$169,128Alina M Allen · Mayo Clinic Rochester · K23 · FY2021 · DK
Noninvasive detection of NASH by magnetic resonance elastography (MRE)
$169,128Alina M Allen · Mayo Clinic Rochester · K23 · FY2022 · DK
Complications and Pathology Core
$169,107John Calvert Rutledge · University Of California At Davis · U24 · FY2011 · DK
Targeted Platinates/siRNA Combination Therapy for Resistant Lung Cancer
$169,106Mansoor M. Amiji · Northeastern University · R21 · FY2014 · CA
The role of FIT2 in VLDL assembly, hepatic triglyceride homeostasis, and lipoprotein atherogenicity
$168,957Edward A Fisher · New York University School Of Medicine · R01 · FY2024 · HL
DMGV and the AGXT2 pathway in chronic exercise-induced cardiometabolic adaptations.
$168,928Jeremy Robbins · Beth Israel Deaconess Medical Center · K23 · FY2022 · HL